Trade

with

Cormedix Inc
(Amex: CRMD)
AdChoices
1.81
-0.04
-2.16%
After Hours :
-
-
-

Open

1.82

Previous Close

1.85

Volume (Avg)

40.98k (60.04k)

Day's Range

1.74-1.84

52Wk Range

0.6600-3.20

Market Cap.

39.82M

Dividend Rate ( Yield )

-

Beta

-0.75

Shares Outstanding

22.00M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 2.00k

    • Net Income

    • -9.13M

    • Market Cap.

    • 39.82M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -35,726.07

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.75

    • Forward P/E

    • -5.40

    • Price/Sales

    • 588.24

    • Price/Book Value

    • -24.88

    • Price/Cash flow

    • -6.05

      • EBITDA

      • -7.68M

      • Return on Capital %

      • -445.48

      • Return on Equity %

      • -

      • Return on Assets %

      • -445.48

      • Book Value/Share

      • -0.07

      • Shares Outstanding

      • 22.00M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 3.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.34

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -525.05

            • 82.75

            • Pre-Tax Margin

            • -35,486.95

            • 39.38

            • Net Profit Margin

            • -35,726.07

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 6.94

              • 2.92

              • Quick Ratio

              • 6.53

              • 2.35

              • Interest Coverage

              • -54.67

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.07

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.69

                • 217.39

                • P/E Ratio 5-Year High

                • -3.73

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.14

                • 124.82

                • Price/Sales Ratio

                • 588.24

                • 9.52

                • Price/Book Value

                • -24.88

                • 8.61

                • Price/Cash Flow Ratio

                • -6.05

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -445.48

                    (-265.20)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 1.21

                  • 1.48

                  • Asset Turnover

                  • 0.01

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -4.92M
                  Operating Margin
                  -245,646.93
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -6.05
                  Ownership

                  Institutional Ownership

                  16.23%

                  Top 10 Institutions

                  17.41%

                  Mutual Fund Ownership

                  1.76%

                  Float

                  94.00%

                  5% / Insider Ownership

                  4.71%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    254,104

                  • 0.00

                  • 1.15

                  • Vanguard Extended Market Index Fund

                  •  

                    81,373

                  • 0.00

                  • 0.37

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    49,454

                  • 0.00

                  • 0.21

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    3,895

                  • 0.00

                  • 0.02

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Millennium Management LLC

                  •  

                    821,899

                  • +4.77%

                  • 3.74

                  • Elliott Management Corp

                  •  

                    781,440

                  • 0.00%

                  • 3.55

                  • Vanguard Group, Inc.

                  •  

                    323,997

                  • +27.91%

                  • 1.47

                  • Geode Capital Management, LLC

                  •  

                    49,454

                  • 0.00%

                  • 0.22

                  • Morgan Stanley Smith Barney LLC

                  •  

                    46,271

                  • +39.07%

                  • 0.21

                  • Northern Trust Investments, N.A.

                  •  

                    27,665

                  • 0.00%

                  • 0.13

                  • Ray Gerald L & Associates Ltd

                  •  

                    16,100

                  • +41.85%

                  • 0.07

                  • Goldman, Sachs & Co.

                  •  

                    10,485

                  • -39.74%

                  • 0.05

                  • FMG LLC

                  •  

                    3,895

                  • 0.00%

                  • 0.02

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  -

                  Cormedix Inc is a development stage pharmaceutical and medical device company. It seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases, including the dialysis and non-dialysis areas.

                  Key People

                  Mr. Randy Milby

                  CEO/Director

                  Mr. Harry OGrady

                  CFO

                  Dr. Antony E. Pfaffle, M.D.

                  Chief Scientific Officer/Director/Secretary

                  Cora M. Tellez

                  Director

                  Michael W. George

                  Director

                  • Cormedix Inc

                  • 745 Route 202-206

                  • Bridgewater, NJ 08807

                  • USA.Map

                  • Phone: +1 908 517-9500

                  • Fax: +1 908 429-4307

                  • cormedix.com

                  Incorporated

                  2006

                  Employees

                  2

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: